This Focused Issue on “HPV vaccine uptake and acceptance in Asia region” is edited by Li Ping Wong, from Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Dr. Wong received her Ph.D. in Medical Science (Epidemiology) from the University of Malaya, Malaysia. She is serving as Professor in the Department of Preventive Medicine, Faculty of Medicine, University of Malaya. She takes part in the Faculty's research methodology and epidemiology teaching both at the undergraduate and graduate levels. Her research has centered almost exclusively on preventive and behavioral medicine, social epidemiology and environmental health. Dr. Wong is also a registered Environmental Impact Assessment (EIA) Consultant with the Department of Environment (DOE) Malaysia under the EIA Consultant Registration Scheme Malaysia. As the first author, corresponding author and co-author, she has published over 120 publications indexed by the Web of Science (Thomson Reuters).
Focused issue outline:
- Gaps and barriers to the access and delivery of HPV vaccination in India
- Facilitators and barriers of human papillomavirus vaccine uptake in young females 18-26 years old in Singapore
- Cost effectiveness of HPV vaccination in Indonesia
- Achieving high uptake of human papillomavirus vaccination in Malaysia through school-based vaccination programme
- Concerning about HPV vaccine's adverse events in Japan
- HPV vaccine literacy among women in Mainland China
- Human papillomavirus public vaccination program in Taiwan: Current practice
- The feasibility of universal HPV vaccination program in China
- Factors influencing intention to obtain the HPV vaccine in South East Asian
- HPV vaccination program in Buthan: Important lessons and strategies
- Overcoming parental misconception about HPV vaccination in Thailand